Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong Xin

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Molecular Biology and Evolution|May 3, 2023
Genomic Evidence for the Nonpathogenic State in HIV-1-Infected Northern Pig-Tailed MacaquesWei Pang, Yong Shao, Xiao-Lin Zhuang, et al.
Acta Pharmacologica Sinica|August 2, 2020
Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2Shu Liu, He Huang, Rong-Xin Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2025
Matrix Stiffness Promotes Invasion and Metastasis of Hepatocellular Carcinoma via a New Mechanoresponsive SCD1/HMMR PathwayHua-Hua Liu, Ye Xu, Wen-Qiang Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining RepairXue-Cen Wang, Xin Yue, Rong-Xin Zhang, et al.
The Lancet. Gastroenterology & Hepatology|March 4, 2023
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studyGong Chen, Ying Jin, Wen-Long Guan, et al.
Medicine|September 2, 2016
Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort studyZhen-Hai Lu, Jian-Hong Peng, Fu-Long Wang, et al.
Theranostics|March 23, 2021
FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cellsJingchun Wang, Huakan Zhao, Lu Zheng, et al.
World Journal of Gastroenterology|April 9, 2015
Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinomaJing-Huan Li, Xiao-Ying Xie, Lan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resectionXin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
JCI Insight|October 4, 2024
Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathyZhong Liu, Shu-Rui Ke, Zhuo-Xing Shi, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Molecular Biology and Evolution|May 3, 2023
Genomic Evidence for the Nonpathogenic State in HIV-1-Infected Northern Pig-Tailed MacaquesWei Pang, Yong Shao, Xiao-Lin Zhuang, et al.
Acta Pharmacologica Sinica|August 2, 2020
Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2Shu Liu, He Huang, Rong-Xin Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2025
Matrix Stiffness Promotes Invasion and Metastasis of Hepatocellular Carcinoma via a New Mechanoresponsive SCD1/HMMR PathwayHua-Hua Liu, Ye Xu, Wen-Qiang Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining RepairXue-Cen Wang, Xin Yue, Rong-Xin Zhang, et al.
The Lancet. Gastroenterology & Hepatology|March 4, 2023
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studyGong Chen, Ying Jin, Wen-Long Guan, et al.
Medicine|September 2, 2016
Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort studyZhen-Hai Lu, Jian-Hong Peng, Fu-Long Wang, et al.
Theranostics|March 23, 2021
FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cellsJingchun Wang, Huakan Zhao, Lu Zheng, et al.
World Journal of Gastroenterology|April 9, 2015
Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinomaJing-Huan Li, Xiao-Ying Xie, Lan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resectionXin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
JCI Insight|October 4, 2024
Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathyZhong Liu, Shu-Rui Ke, Zhuo-Xing Shi, et al.
Pageof 34